# Atea Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Apr 17, 2025

- Company: [Atea Pharmaceuticals, Inc.](/companies/avir.md) (CIK 1593899)
- Form: SCHEDULE 13D/A
- Filed: 2025-04-17
- Accepted by EDGAR: Apr 17, 2025, 16:23 ET
- Period: not reported
- Accession: 0000921895-25-001112
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1593899/000092189525001112/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1593899/000092189525001112/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1593899/000092189525001112/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 17, 2025.
Source: SEC EDGAR, the filing index for accession 0000921895-25-001112. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.